Alaunos Therapeutics, Inc.

Alaunos Therapeutics, Inc.verified

TCRT

Price:

$3.59

Market Cap:

$8.01M

Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers; hunTR, a human neoantigen T-cell receptor platform; and mbIL-15 to treat solid tumors. Alaunos Therapeutics, Inc. has a license agreement with PGEN Therapeutics, Inc.; research and development agreement with The University of Texas MD Anderson Cancer Center; and a patent license agreement, and research and developm...[Read more]

Industry

Biotechnology

IPO Date

2005-08-24

Stock Exchange

NASDAQ

Ticker

TCRT

The PE Ratio as of December 2025 (TTM) for Alaunos Therapeutics, Inc. (TCRT) is -1.56

According to Alaunos Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.56. This represents a change of -99.45% compared to the average of -284.59 of the last 4 quarters.

Alaunos Therapeutics, Inc. (TCRT) Historical PE Ratio (quarterly & annually)

How has TCRT PE Ratio performed in the past?

The mean historical PE Ratio of Alaunos Therapeutics, Inc. over the last ten years is -4.75. The current -1.56 PE Ratio has changed 3.19% with respect to the historical average. Over the past ten years (40 quarters), TCRT's PE Ratio was at its highest in in the December 2023 quarter at -0.54. The PE Ratio was at its lowest in in the September 2025 quarter at -1134.84.

Quarterly (TTM)
Annual

Average

-4.75

Median

-4.34

Minimum

-10.44

Maximum

-0.48

Alaunos Therapeutics, Inc. (TCRT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Alaunos Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 147.29%

Maximum Annual PE Ratio = -0.48

Minimum Annual Increase = -87.12%

Minimum Annual PE Ratio = -10.44

Quarterly (TTM)
Annual
YearPE RatioChange
2024-0.6535.34%
2023-0.48-87.12%
2022-3.7523.35%
2021-3.04-54.64%
2020-6.7050.37%
2019-4.46-11.81%
2018-5.05-51.59%
2017-10.44147.29%
2016-4.22-51.37%
2015-8.68-46.21%

Alaunos Therapeutics, Inc. (TCRT) Average PE Ratio

How has TCRT PE Ratio performed in the past?

The current PE Ratio of Alaunos Therapeutics, Inc. (TCRT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-1.63

5-year avg

-2.92

10-year avg

-4.75

Alaunos Therapeutics, Inc. (TCRT) PE Ratio vs. Peers

How is TCRT’s PE Ratio compared to its peers?

Alaunos Therapeutics, Inc.’s PE Ratio is less than Radiopharm Theranostics Limited (0), greater than Cyclerion Therapeutics, Inc. (-2.49), less than Pasithea Therapeutics Corp. (-0.00), less than VYNE Therapeutics Inc. (-0.48), less than Quoin Pharmaceuticals, Ltd. (-0.91), less than Addex Therapeutics Ltd (-0.90), greater than Polyrizon Ltd. (-21.85), less than AIM ImmunoTech Inc. (-0.20), greater than XTL Biopharmaceuticals Ltd. (-4.14), less than Impact BioMedical Inc. (-0.15),

Build a custom stock screener for Alaunos Therapeutics, Inc. (TCRT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alaunos Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alaunos Therapeutics, Inc. (TCRT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alaunos Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Alaunos Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Alaunos Therapeutics, Inc. (TCRT)?

What is the highest PE Ratio for Alaunos Therapeutics, Inc. (TCRT)?

What is the 3-year average PE Ratio for Alaunos Therapeutics, Inc. (TCRT)?

What is the 5-year average PE Ratio for Alaunos Therapeutics, Inc. (TCRT)?

How does the current PE Ratio for Alaunos Therapeutics, Inc. (TCRT) compare to its historical average?